Skip to main content
NCD 20.7 · version 11

NCD 20.7: Percutaneous Transluminal Angioplasty (PTA)

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 20.7

Benefit category
Inpatient Hospital Services, Physicians' Services
Effective date
10/11/2023
Implemented 05/13/2024
Transmittal
Transmittal 12571
Versions published
11
Manual section
20
Cardiovascular System, NCD Manual (Pub. 100-03) chapter 1 part 1

TL;DR

NCD 20.7 sets Medicare's national policy for percutaneous transluminal angioplasty (pta) under the benefit category "Inpatient Hospital Services, Physicians' Services", effective 10/11/2023 and implemented 05/13/2024. -In the lower extremities, i.e., the iliac, femoral, and popliteal arteries, or in the upper extremities, i.e., the innominate, subclavian, axillary, and brachial arteries. The upper extremities do not include head or neck vessels. It has been revised 10 times since publication and binds every Medicare Administrative Contractor nationally.

Item or service described

A. General

This procedure involves inserting a balloon catheter into a narrow or occluded blood vessel to recanalize and dilate the vessel by inflating the balloon. The objective of percutaneous transluminal angioplasty (PTA) is to improve the blood flow through the diseased segment of a vessel so that vessel patency is increased and embolization is decreased. With the development and use of balloon angioplasty for treatment of atherosclerotic and other vascular stenoses, PTA (with and without the placement of a stent) is a widely used technique for dilating lesions of peripheral, renal, and coronary arteries.

Indications and limitations of coverage

B. Nationally Covered Indications

The PTA is covered when used under the following conditions:

1. Treatment of Atherosclerotic Obstructive Lesions

-In the lower extremities, i.e., the iliac, femoral, and popliteal arteries, or in the upper extremities, i.e., the innominate, subclavian, axillary, and brachial arteries. The upper extremities do not include head or neck vessels.

-Of a single coronary artery for patients for whom the likely alternative treatment is coronary bypass surgery and who exhibit the following characteristics:

• Angina refractory to optimal medical management;

• Objective evidence of myocardial ischemia; and

• Lesions amenable to angioplasty

-Of the renal arteries for patients in whom there is an inadequate response to a thorough medical management of symptoms and for whom surgery is the likely alternative. PTA for this group of patients is an alternative to surgery, not simply an addition to medical management.

-Of arteriovenous dialysis fistulas and grafts when performed through either a venous or arterial approach.

2. Concurrent with Carotid Stent Placement in Food and Drug Administration (FDA)-Approved Category B Investigational Device Exemption (IDE) Clinical Trials

Effective July 1, 2001, Medicare covers PTA of the carotid artery concurrent with carotid stent placement when furnished in accordance with the FDA-approved protocols governing Category B IDE clinical trials. PTA of the carotid artery, when provided solely for the purpose of carotid artery dilation concurrent with carotid stent placement, is considered to be a reasonable and necessary service when provided in the context of such a clinical trial.

3. Concurrent with Carotid Stent Placement in FDA-Approved Post-Approval Studies

Effective October 12, 2004, Medicare covers PTA of the carotid artery concurrent with the placement of an FDA-approved carotid stent and an FDA-approved or –cleared embolic protection device (effective December 9, 2009) for an FDA-approved indication when furnished in accordance with FDA-approved protocols governing post-approval studies. The Centers for Medicare & Medicaid Services (CMS) determines that coverage of PTA of the carotid artery is reasonable and necessary in these circumstances.

4. Concurrent with Carotid Stent Placement

Effective October 11, 2023, CMS covers PTA of the carotid artery concurrent with stenting with the placement of an FDA-approved carotid stent with an FDA-approved or cleared embolic protection device, for Medicare beneficiaries under the following conditions:

A. Patients with symptomatic carotid artery stenosis ≥50%; and,

B. Patients with asymptomatic carotid artery stenosis ≥70%.

For both A and B above:

1. Neurological assessment by a neurologist or NIH stroke scale (NIHSS) certified health professional before and after CAS must be performed.

2. First-line evaluation of carotid artery stenosis must use duplex ultrasound.

3. Computed tomography angiography or magnetic resonance angiography, if not contraindicated, must be used to confirm the degree of stenosis and provide additional information about the aortic arch, and extra- and intra-cranial circulation.

4. Intra-arterial digital subtraction (catheter) angiography may be used only when there is significant

discrepancy between non-invasive imaging results, or in lieu of computed tomography angiography or magnetic resonance angiography if these are contraindicated.

Prior to furnishing CAS, the practitioner must engage in a formal shared decision-making interaction with the beneficiary. The shared decision-making interaction must include:

• Discussion of all treatment options including carotid endarterectomy (CEA), CAS (which includes transcarotid artery revascularization (TCAR), and optimal medical therapy (OMT)).

• Explanation of risks and benefits for each option specific to the beneficiary’s clinical situation.

• Integration of clinical guidelines (e.g., patient comorbidities and concomitant treatments).

• Discussion and incorporation of beneficiary’s personal preferences and priorities in choosing a treatment plan.

Facilities must establish and maintain institutional and physician standards to support a dedicated carotid stent program. These standards must at least include and ensure the following:

• Facilities have a clearly delineated program for granting carotid stent privileges and for monitoring patient outcomes for individual physicians and the program as a whole.

• The oversight committee for this program shall be empowered to identify the minimum case volume for a physician to maintain privileges, as well as the (risk-adjusted) threshold for complications that the institution will allow before suspending privileges or instituting measures for remediation. Committees are encouraged to apply published standards from specialty societies and widely-used, published professional society guidelines to determine appropriate physician qualifications.

• Facilities have appropriately trained staff capable of fulfilling roles and responsibilities as delineated under the dedicated carotid stent program.

• Facilities have appropriate supporting personnel and equipment for imaging, emergency management, advanced physiologic monitoring, and other ancillary care.

• Facilities must ensure continuous quality improvement by assessing procedural outcomes and making necessary programmatic adjustments to assure patient safety.

5. Concurrent with Intracranial Stent Placement in FDA-Approved Category B IDE Clinical Trials

Effective November 6, 2006, Medicare covers PTA and stenting of intracranial arteries for the treatment of cerebral artery stenosis ≥50% in patients with intracranial atherosclerotic disease when furnished in accordance with the FDA-approved protocols governing Category B IDE clinical trials. CMS determines that coverage of intracranial PTA and stenting is reasonable and necessary under these circumstances.

C. Nationally Non-Covered Indications

All other indications for PTA with or without stenting to treat obstructive lesions of the vertebral and cerebral arteries remain non-covered.

All other indications for PTA without stenting for which CMS has not specifically indicated coverage remain non-covered.

D. Other

In addition to the national coverage described above, Medicare Administrative Contractors (MACs) may make reasonable and necessary determinations under section 1862(a)(1)(A) of the Social Security Act for any other beneficiary seeking coverage for PTA of the carotid artery concurrent with stenting.

Coverage of PTA with stenting not specifically addressed or discussed in this NCD is at the discretion of the MACs.

(This NCD last reviewed October 2023)

Text reproduced from the CMS Medicare Coverage Database record for NCD 20.7 version 11. View the original on cms.gov.

Local policies that build on this NCD

8 active Local Coverage Determinations cite NCD 20.7 among their related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 20.7

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 4 current articles in the Medicare Coverage Database name NCD 20.7, 4 of them with a covered ICD-10-CM list, from 3 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 20.7
ContractorArticles
Palmetto GBAA60247
Wellpoint FederalA56823
Wisconsin Physicians Service Insurance CorporationA57479, A57590

A56823: Billing and Coding: Percutaneous Coronary Intervention

Billing and Coding, effective 2026-04-01 · Wellpoint Federal (06101, 06102, 06201, 06202, 06301, 06302, 13101, 13102, 13201, 13202, 13282, 13292, 14111, 14112, 14211, 14212, 14311, 14312, 14411, 14412, 14511, 14512) · CMS record

103 covered ICD-10-CM codes; 22 procedure codes: 92920, 92924, 92928, 92930, 92933, 92937, 92941, 92943, 92973, 92978, 92979, 93571 and 10 more. Local policy: L33623 Percutaneous Coronary Intervention. Check a diagnosis for 92920.

First covered codes: I20.0 Unstable angina; I20.81 Angina pectoris with coronary microvascular dysfunction; I20.89 Other forms of angina pectoris; I20.9 Angina pectoris, unspecified; I21.01 ST elevation (STEMI) myocardial infarction involving left main coronary artery; I21.02 ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery; …

A57479: Billing and Coding: Percutaneous Coronary Interventions

Billing and Coding, effective 2026-01-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

89 covered ICD-10-CM codes; 24 procedure codes: 92920, 92924, 92928, 92930, 92933, 92937, 92941, 92943, 92945, 92973, 92974, 92978 and 12 more. Local policy: L34761 Percutaneous Coronary Interventions. Check a diagnosis for 92920.

First covered codes: I20.0 Unstable angina; I20.1 Angina pectoris with documented spasm; I20.81 Angina pectoris with coronary microvascular dysfunction; I20.89 Other forms of angina pectoris; I20.9 Angina pectoris, unspecified; I21.01 ST elevation (STEMI) myocardial infarction involving left main coronary artery; …

A57590: Billing and Coding: Non-Coronary Vascular Stents

Billing and Coding, effective 2026-01-01 · Wisconsin Physicians Service Insurance Corporation (05101, 05102, 05201, 05202, 05301, 05302, 05401, 05402, 05901, 08101, 08102, 08201, 08202) · CMS record

280 covered ICD-10-CM codes in 9 groups; 50 procedure codes: 37236, 37237, 37238, 37239, 37254, 37255, 37256, 37257, 37258, 37259, 37260, 37261 and 38 more. Local policy: L35998 Non-Coronary Vascular Stents. Check a diagnosis for 37236.

First covered codes: G45.8 Other transient cerebral ischemic attacks and related syndromes; I70.218 Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity; I70.228 Atherosclerosis of native arteries of extremities with rest pain, other extremity; I70.25 Atherosclerosis of native arteries of other extremities with ulceration; I70.268 Atherosclerosis of native arteries of extremities with gangrene, other extremity; I72.1 Aneurysm of artery of upper extremity; …

A60247: Billing and Coding: Endovascular Management for Peripheral Arterial Disease of the Upper and Lower Extremities

Billing and Coding, effective 2026-04-12 · Palmetto GBA (10111, 10112, 10211, 10212, 10311, 10312, 11201, 11202, 11301, 11302, 11401, 11402, 11501, 11502) · CMS record

212 covered ICD-10-CM codes in 2 groups; 70 procedure codes: 0237T, 0238T, 0505T, 0620T, 37184, 37185, 37186, 37236, 37237, 37242, 37243, 37244 and 58 more. Local policy: L40228 Endovascular Management for Peripheral Arterial Disease of the Upper and Lower Extremities. Check a diagnosis for 0237T.

First covered codes: I70.208 Unspecified atherosclerosis of native arteries of extremities, other extremity; I70.218 Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity; I70.228 Atherosclerosis of native arteries of extremities with rest pain, other extremity; I70.25 Atherosclerosis of native arteries of other extremities with ulceration; I70.268 Atherosclerosis of native arteries of extremities with gangrene, other extremity; I70.298 Other atherosclerosis of native arteries of extremities, other extremity; …

Coverage analysis history

CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links 10 analyses to NCD 20.7, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.

  1. CAG-00085N Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting (New, Closed)
  2. CAG-00259N Carotid Artery Stenting in Post-Approval Studies (New, Closed)
  3. CAG-00085R Carotid Artery Stenting (1st Recon, Closed)
  4. CAG-00085R2 Intracranial Stenting and Angioplasty (2nd Recon, Closed)
  5. CAG-00085R3 Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting (3rd Recon, Closed)
  6. CAG-00085R4 Percutaneous Transluminal Angioplasty (PTA) and Stenting of the Renal Arteries (4th Recon, Closed)
  7. CAG-00085R5 Intracranial Stenting and Angioplasty (5th Recon, Closed)
  8. CAG-00085R6 Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting (6th Recon, Closed)
  9. CAG-00085R7 Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting (7th Recon, Closed)
  10. CAG-00085R8 Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting (8th Recon, Closed)

Revision history

04/2024 - Transmittal 12571 issued April 11, 2024, The purpose of this Change Request (CR) is to make contractors aware of policy updates for Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with

Stenting sections B4 and D of NCD 20.7. ( TN 12571 ) (CR13512)

04/2023 - Transmittal 11884 issued March 01, 2023, is being rescinded and replaced by Transmittal 11952, dated, April 12, 2023, to remove the A/B MACs (Part A) and FISS from BR 13070.1 and to revise the NCD 20.4 Implantable Automatic Defibrillators (ICDs) spreadsheet. All other information remains the same. ( TN 11952 ) (CR13070)

02/2023 - The purpose of the Change Request (CR) is to provide a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received. ( TN 11832 ) (CR13070)

09/2019 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received. ( TN 2362 ) (CR11392)

01/2019 - This Change Request (CR) contains language-only changes for updating the New Medicare Card Project-related language in Pub 100-03. There are no new coverage policies, payment policies, or codes introduced in this transmittal. Specific policy changes and related business requirements have been announced previously in various communications. ( TN 212 ) (CR11118)

11/2018 - This Change Request (CR) constitutes a maintenance update of ICD-10 conversions and other coding updates specific to NCDs. These NCD coding changes are the result of newly available codes, coding revisions to NCDs released separately, or coding feedback received.

Previous NCD coding changes appear in ICD-10 quarterly updates that can be found at: https://www.cms.gov/Medicare/Coverage/CoverageGenInfo/ICD10.html , along with other CRs implementing new policy NCDs. Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent quarterly releases and individual CRs as appropriate. No policy-related changes are included with the ICD-10 quarterly updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process.( TN 2202 ) (CR11005)

11/2016 - This change request (CR) is the 9th maintenance update of ICD-10 conversions and other coding updates specific to national coverage determinations (NCDs). The majority of the NCDs included are a result of feedback received from previous ICD-10 NCD CR7818, CR8109, CR8197, CR8691, CR9087, CR9252, CR9540, and CR9631. Some are the result of revisions required to other NCD-related CRs released separately.

Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent, quarterly releases as needed. No policy-related changes are included with these updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process. ( TN 1753 ) (CR9751)

08/2016 - This change request (CR) is the 9th maintenance update of ICD-10 conversions and other coding updates specific to national coverage determinations (NCDs). The majority of the NCDs included are a result of feedback received from previous ICD-10 NCD CR7818, CR8109, CR8197, CR8691, CR9087, CR9252, CR9540, and CR9631. Some are the result of revisions required to other NCD-related CRs released separately.

Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent, quarterly releases as needed. No policy-related changes are included with these updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process. ( TN 1708 ) (CR9751)

06/2016 - Transmittal 1665, dated May 13, 2016, is being rescinded and replaced by Transmittal 1672 to: (1) 9631.1: Remove FISS responsibility and 1st sentence; (2) 9631.2: Remove additional procedure codes, including 0075T, 0076T; (3) 9631.4: Revise descriptor of dx L59.8; (4) 9631.6: Add deletion of dx C49.10, C65.9, remove deletion of dx C54.9, remove deletion of invalid dx C47.90; (5) 9631.8: Remove deletion of invalid dx C51.29, replace with deletion of dx C50.029; (6) 9631.9: Add deletion of 0V504ZZ, 0V500ZZ, override capability, and contractor discretion verbiage. All other information remains the same. ( TN 1672 ) (CR9631)

05/2016 - This change request (CR) is the 7th maintenance update of ICD-10 conversions and other coding updates specific to national coverage determinations (NCDs). The majority of the NCDs included are a result of feedback received from previous ICD-10 NCD CR7818, CR8109, CR8197, CR8691, CR9087, CR9252, and CR9540. Some are the result of revisions required to other NCD-related CRs released separately.

Edits to ICD-10 and other coding updates specific to NCDs will be included in subsequent, quarterly releases as needed. No policy-related changes are included with these updates. Any policy-related changes to NCDs continue to be implemented via the current, long-standing NCD process. ( TN 1665 ) (CR9631)

12/2015 - This change request (CR) is the 3rd maintenance update of ICD-10 conversions/updates specific to national coverage determinations (NCDs). The majority of the NCDs included are a result of feedback received from previous ICD-10 NCD CR7818, CR8109, CR8197, CR8691, & CR9087. Some are the result of revisions required to other NCD-related CRs released separately that included ICD-10 coding. Implementation date: 01/04/2016 Effective date: 10/1/2015. ( TN 1580 ) (CR9252)

08/2015 - This change request (CR) is the 3rd maintenance update of ICD-10 conversions/updates specific to national coverage determinations (NCDs). The majority of the NCDs included are a result of feedback received from previous ICD-10 NCD CR7818, CR8109, CR8197, CR8691, & CR9087. Some are the result of revisions required to other NCD-related CRs released separately that included ICD-10 coding.

These updates do not expand, restrict, or alter existing coverage policy. Implementation date: 01/04/2016 Effective date: 10/1/2015. ( TN 1537 ) (CR 9252)

05/2014 - CMS translated the information for this policy from ICD-9-CM/PCS to ICD-10-CM/PCS according to HIPAA standard medical data code set requirements and updated any necessary and related coding infrastructure. These updates do not expand, restrict, or alter existing coverage policy. Implementation date: 10/06/2014 Effective date: 10/1/2015. ( TN 1388 ) ( TN 1388 ) (CR 8691)

03/2013 - CMS translated the information for this policy from ICD-9-CM/PCS to ICD-10-CM/PCS according to HIPAA standard medical data code set requirements and updated any necessary and related coding infrastructure. These updates do not expand, restrict, or alter existing coverage policy. Implementation date: 10/07/2013 Effective date: 10/1/2015. ( TN 1199 ) ( TN 1199 ) (CR 8197)

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 20.7

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 20.7

What does NCD 20.7 cover?

The PTA is covered when used under the following conditions: The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 20.7 take effect?

The current version (11) is effective 10/11/2023, implemented 05/13/2024, published in transmittal 12571. CMS lists 11 versions of this NCD.

Does a Local Coverage Determination override NCD 20.7?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.